Stockholm-based health technology firm Neko Health has raised $700 million in a Series C funding round led by Lightspeed Venture Partners and co-led by O.G. Venture Partners, with participation from Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum, and BDT & MSD Partners.
- Founded in 2023 by Daniel Ek and Hjalmar Nilsonne, Neko Health focuses on preventive healthcare and early disease detection. The company develops proprietary medical scanning hardware, software, and data analysis systems designed to capture and interpret a wide range of health signals.
- Its core product, the Neko Health Scan, combines sensor technology, blood analysis, and clinical assessments to collect millions of data points related to areas such as skin health, cardiovascular risk, metabolic markers, and other indicators of potential health issues.
- During a scan, members undergo a non-invasive assessment lasting about an hour, after which the collected data is reviewed by clinicians who provide a health report and discuss findings with the individual.
- The company operates its own clinics and builds its technology stack in-house, allowing it to control the scanning process, data analysis, and clinical experience.
Details of the deal
- The aim of the round is to scale Neko Health’s preventive healthcare platform by expanding into the US, including opening its first New York clinic, advancing research into early disease detection, and continuing development of its proprietary health scanning technology.
